Multiplexed mass cytometry profiling of cellular states perturbed by small-molecule regulators

被引:384
作者
Bodenmiller, Bernd [1 ]
Zunder, Eli R. [1 ]
Finck, Rachel [1 ]
Chen, Tiffany J. [1 ,2 ,3 ]
Savig, Erica S. [1 ,4 ]
Bruggner, Robert V. [1 ,2 ]
Simonds, Erin F. [1 ]
Bendall, Sean C. [1 ]
Sachs, Karen [1 ]
Krutzik, Peter O. [1 ]
Nolan, Garry P. [1 ]
机构
[1] Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA
[2] Stanford Univ, Biomed Informat Program, Stanford, CA 94305 USA
[3] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA
[4] Stanford Univ, Canc Biol Program, Stanford, CA 94305 USA
基金
瑞士国家科学基金会;
关键词
KINASE INHIBITOR SELECTIVITY; POLYCHROMATIC FLOW-CYTOMETRY; FUNCTIONAL GENOMICS; DRUG DISCOVERY; IMMUNE-SYSTEM; CANCER; CELLS; PROTEOMICS; RESPONSES; POPULATIONS;
D O I
10.1038/nbt.2317
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Mass cytometry facilitates high-dimensional, quantitative analysis of the effects of bioactive molecules on human samples at single-cell resolution, but instruments process only one sample at a time. Here we describe mass-tag cellular barcoding (MCB), which increases mass cytometry throughput by using n metal ion tags to multiplex up to 2(n) samples. We used seven tags to multiplex an entire 96-well plate, and applied MCB to characterize human peripheral blood mononuclear cell (PBMC) signaling dynamics and cell-to-cell communication, signaling variability between PBMCs from eight human donors, and the effects of 27 inhibitors on this system. For each inhibitor, we measured 14 phosphorylation sites in 14 PBMC types at 96 conditions, resulting in 18,816 quantified phosphorylation levels from each multiplexed sample. This high-dimensional, systems-level inquiry allowed analysis across cell-type and signaling space, reclassified inhibitors and revealed off-target effects. High-content, high-throughput screening with MCB should be useful for drug discovery, preclinical testing and mechanistic investigation of human disease.
引用
收藏
页码:858 / U89
页数:12
相关论文
共 50 条
  • [11] Phosphoproteomic Analysis Reveals Interconnected System-Wide Responses to Perturbations of Kinases and Phosphatases in Yeast
    Bodenmiller, Bernd
    Wanka, Stefanie
    Kraft, Claudine
    Urban, Joerg
    Campbell, David
    Pedrioli, Patrick G.
    Gerrits, Bertran
    Picotti, Paola
    Lam, Henry
    Vitek, Olga
    Brusniak, Mi-Youn
    Roschitzki, Bernd
    Zhang, Chao
    Shokat, Kevan M.
    Schlapbach, Ralph
    Colman-Lerner, Alejandro
    Nolan, Garry P.
    Nesvizhskii, Alexey I.
    Peter, Matthias
    Loewith, Robbie
    von Mering, Christian
    Aebersold, Ruedi
    [J]. SCIENCE SIGNALING, 2010, 3 (153)
  • [12] Interlinked fast and slow positive feedback loops drive reliable cell decisions
    Brandman, O
    Ferrett, JE
    Li, R
    Meyer, T
    [J]. SCIENCE, 2005, 310 (5747) : 496 - 498
  • [13] Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometry
    Chattopadhyay, Pratip K.
    Price, David A.
    Harper, Theresa F.
    Betts, Michael R.
    Yu, Joanne
    Gostick, Emma
    Perfetto, Stephen P.
    Goepfert, Paul
    Koup, Richard A.
    De Rosa, Stephen C.
    Bruchez, Marcel P.
    Roederer, Mario
    [J]. NATURE MEDICINE, 2006, 12 (08) : 972 - 977
  • [14] Comprehensive analysis of kinase inhibitor selectivity
    Davis, Mindy I.
    Hunt, Jeremy P.
    Herrgard, Sanna
    Ciceri, Pietro
    Wodicka, Lisa M.
    Pallares, Gabriel
    Hocker, Michael
    Treiber, Daniel K.
    Zarrinkar, Patrick P.
    [J]. NATURE BIOTECHNOLOGY, 2011, 29 (11) : 1046 - U124
  • [15] U.S. Food and Drug Administration Approval: Ruxolitinib for the Treatment of Patients with Intermediate and High-Risk Myelofibrosis
    Deisseroth, Albert
    Kaminskas, Edvardas
    Grillo, Joseph
    Chen, Wei
    Saber, Haleh
    Lu, Hong L.
    Rothmann, Mark D.
    Brar, Satjit
    Wang, Jian
    Garnett, Christine
    Bullock, Julie
    Burke, Laurie B.
    Rahman, Atiqur
    Sridhara, Rajeshwari
    Farrell, Ann
    Pazdur, Richard
    [J]. CLINICAL CANCER RESEARCH, 2012, 18 (12) : 3212 - 3217
  • [16] Pharmacogenomics: Translating functional genomics into rational therapeutics
    Evans, WE
    Relling, MV
    [J]. SCIENCE, 1999, 286 (5439) : 487 - 491
  • [17] A small molecule-kinase interaction map for clinical kinase inhibitors
    Fabian, MA
    Biggs, WH
    Treiber, DK
    Atteridge, CE
    Azimioara, MD
    Benedetti, MG
    Carter, TA
    Ciceri, P
    Edeen, PT
    Floyd, M
    Ford, JM
    Galvin, M
    Gerlach, JL
    Grotzfeld, RM
    Herrgard, S
    Insko, DE
    Insko, MA
    Lai, AG
    Lélias, JM
    Mehta, SA
    Milanov, ZV
    Velasco, AM
    Wodicka, LM
    Patel, HK
    Zarrinkar, PP
    Lockhart, DJ
    [J]. NATURE BIOTECHNOLOGY, 2005, 23 (03) : 329 - 336
  • [18] Protein Dynamics in Drug Combinations: a Linear Superposition of Individual-Drug Responses
    Geva-Zatorsky, Naama
    Dekel, Erez
    Cohen, Ariel A.
    Danon, Tamar
    Cohen, Lydia
    Alon, Uri
    [J]. CELL, 2010, 140 (05) : 643 - 651
  • [19] Cell Sorting: Automated Separation of Mammalian Cells as a Function of Intracellular Fluorescence
    Hulett, H. R.
    Bonner, W. A.
    Barrett, Janet
    Herzenberg, Leonard A.
    [J]. JOURNAL OF IMMUNOLOGY, 2014, 193 (05) : 747 - 749
  • [20] ERBB receptors and cancer: The complexity of targeted inhibitors
    Hynes, NE
    Lane, HA
    [J]. NATURE REVIEWS CANCER, 2005, 5 (05) : 341 - 354